News on Mesothelioma | Surviving Mesothelioma

High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms

High dose radiotherapy may work wonders for some kinds of cancer but it is not recommended as a way to manage the symptoms of pleural mesothelioma. That word comes from a group of mesothelioma experts in one of the world’s mesothelioma hot spots – Melbourne, Australia. Australia has the dubious distinction of having one of the highest rates of malignant mesothelioma in the world due to … Continue reading High Dose Radiotherapy Not Recommended for Managing Mesothelioma Symptoms »

IMRT “Feasible and Effective” for Pleural Mesothelioma

When malignant pleural mesothelioma patients receive radiation therapy in the form of IMRT (intensity modulated radiation therapy) at an experienced institution, the treatment can be both feasible and effective. That is the conclusion of Dr. Kenneth Rosenzweig, Chairman of the Department of Radiation Oncology at Mount Sinai School of Medicine in New York. Rosenzweig is the author of a new summary of radiation therapy in … Continue reading IMRT “Feasible and Effective” for Pleural Mesothelioma »

Study to Test New Three-Drug Treatment for Pleural Mesothelioma

The makers of a VEGF-inhibitor called nintedanib are recruiting patients with unresectable pleural mesothelioma for a Phase III clinical trial of the drug in combination with standard chemotherapy. The multicenter trial sponsored by drug maker Boehringer Ingelheim will eventually include a total of 450 mesothelioma patients, but preliminary results from the first 87 patients look promising.  According to data presented at the 2017 American Society of Clinical Oncology … Continue reading Study to Test New Three-Drug Treatment for Pleural Mesothelioma »

Mayo Researchers Fight Mesothelioma with Measles Virus

The same virus that can make unvaccinated children come down with spots and fevers may provide the basis for a powerful new weapon against the intractable cancer, malignant pleural mesothelioma. New research being conducted at the University of Minnesota and the Mayo Clinic suggests that a strain of the measles virus called MV-Edm (the Edmonston strain) has the unique ability to not only target and … Continue reading Mayo Researchers Fight Mesothelioma with Measles Virus »

BAP1 May Not Be The Only Gene to Increase Mesothelioma RIsk

The question of why some asbestos-exposed people develop malignant mesothelioma and others do not has been a key focus of mesothelioma research for more than a decade. We now know that a mutation in the BAP1 gene can predispose certain people to several types of cancer, including mesothelioma. This is known as BAP1 cancer syndrome. Without the BAP1 tumor-suppressing protein to keep it at bay, … Continue reading BAP1 May Not Be The Only Gene to Increase Mesothelioma RIsk »

Chamomile Tea May Hold the Secret to Longer Mesothelioma Survival

A new study suggests that a flavonoid found in parsley, celery, and chamomile tea may help improve the odds of surviving malignant mesothelioma. Scientists in Italy have just released some promising findings from tests of the compound apigenin on mesothelioma cells in the lab and in live mice. What is Apigenin? Apigenin is a plant pigment that is part of a larger group of chemicals … Continue reading Chamomile Tea May Hold the Secret to Longer Mesothelioma Survival »

New Mesothelioma Study: Asbestos Fiber Burden Does Not Decline With Time

Mesothelioma has one of the longest latency periods of any disease. It is not unusual for patients to develop the asbestos cancer many decades after their last exposure to asbestos. Now, a new German study offers a more detailed explanation of why that is. Although the body is adept at ridding itself of many kinds of toxins, when asbestos fibers are inhaled or swallowed, their … Continue reading New Mesothelioma Study: Asbestos Fiber Burden Does Not Decline With Time »

Osteoporosis Drug May Help Treat Advanced Mesothelioma, Too

A drug normally used to treat and prevent osteoporosis may be useful in the treatment of advanced malignant mesothelioma, too. The drug, called zoledronic acid, is a member of the drug class bisphosphonates and is also used to prevent skeletal fractures in patients with certain kinds of cancer.   In a new study published in the journal Lung Cancer, University of Alabama researchers found that more than … Continue reading Osteoporosis Drug May Help Treat Advanced Mesothelioma, Too »

Compound in Broccoli May Enhance Mesothelioma Treatment with Cisplatin

There is new evidence that a compound found in cruciferous vegetables like broccoli and cabbage may enhance the anticancer benefits of the platinum-based drug cisplatin in the treatment of pleural mesothelioma. Although malignant mesothelioma is highly resistant to conventional cancer treatments, most mesothelioma patients will receive chemotherapy with cisplatin and pemetrexed (Alimta) as part of a multi-modal approach to treatment. Now, researchers Yoon-Jin and Sang-Han … Continue reading Compound in Broccoli May Enhance Mesothelioma Treatment with Cisplatin »

MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma

Australian scientists say it may be possible to artificially reduce the levels of a protein that helps mesothelioma tumors hide from the immune system. The new research published in the Journal of Thoracic Oncology could open the door to more effective immunotherapy treatments for pleural mesothelioma. The Importance of PD-L1 Expression A cell surface protein called PD-L1 is key to the effectiveness of several new … Continue reading MicroRNAs May Be Key to Better Immunotherapy for Mesothelioma »

Get your free copy of
“Surviving Mesothelioma” Today!